Bank of America’s Guardant Health GH Stock Holding History

Bank of America’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$1.03M	–	8291
2024 Q1	$1.03M	Buy	+50,000	New	+$1.07M	﹤0.01%	4917
2021 Q3	–	Sell	-22,200	Closed	-$2.76M	–	8208
2021 Q2	$2.76M	Sell	22,200 -23,100	-51%	-$3.11M	﹤0.01%	4056
2021 Q1	$6.92M	Buy	45,300 +20,300	+81%	+$3.07M	﹤0.01%	3070
2020 Q4	$3.22M	Hold	25,000	–	–	﹤0.01%	3532
2020 Q3	$2.79M	Hold	25,000	–	–	﹤0.01%	3416
2020 Q2	$2.03M	Hold	25,000	–	–	﹤0.01%	3621
2020 Q1	$1.74M	Sell	25,000 -14,200	-36%	-$1.09M	﹤0.01%	3588
2019 Q4	$3.06M	Sell	39,200 -44,300	-53%	-$3.19M	﹤0.01%	3675
2019 Q3	$5.33M	Buy	+83,500	New	+$7.36M	﹤0.01%	3139

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America's GH Position: Q1 2026 in Review

Bank of America reduced its Guardant Health (GH) stake by 12% in Q1 2026, selling an estimated $12.3M and leaving 895,221 shares worth $82.7M. The position accounts for 0.01% of the portfolio, ranked #1261.

Bank of America first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $162M in Q1 2021. 483 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Bank of America held 895,221 shares of Guardant Health worth $82.7M as of Q1 2026.
Bank of America sold 122,425 Guardant Health shares in Q1 2026, an estimated $12.3M.
Guardant Health made up 0.01% of Bank of America's portfolio in Q1 2026, its #1261 holding.
Bank of America first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
Bank of America's Guardant Health position peaked at $162M in Q1 2021.
483 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.